From: Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses
Type of cancer
AUC* (±SEM)
Sensitivity (%)
Specificity (%)
Criterion (ng/ml)
BC/NMF
0.911 ± 0.0179
89.3
78.0
>32.3390
BC/CRC
0.765 ± 0.0388
88.8
58.7
>33.5024
BC/KC
0.809 ± 0.0461
75.6
76.7
>35.3212
BC/LC
0.773 ± 0.0281
55.0
>32.2963